Anterior vs Valer (Voluware)
Two Prior Authorization vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Anterior | Valer (Voluware) | |
|---|---|---|
| Pricing model | Enterprise contract (custom) · Payer enterprise deals only | Not published · custom quotes for health systems |
| Speed to go live | Embedded team, deep payer integration | customized to each workflow and EHR |
| Automation model | AI copilot · Clinician-in-loop utilization review | Software platform · single portal for all payers |
| Built for | Payers | Mid-size groups, Enterprise systems |
| Security posture | HIPAA | HITRUST |
| Company maturity | 3 yrs (est. 2023) | 14 yrs (est. 2012) |
| Financial backing | $64M · Series B | PE-backed (Hughes & Company) |
| Named customers | 1 named | 1 named |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 1 listed | 4 listed |
| Third-party validation | KLAS / analyst cited | None found |
Bottom line
- Pick Anterior if you are a health plan that wants clinician-supervised AI to cut prior auth review time while keeping final decisions with your own staff.
- Pick Valer if your staff juggles dozens of payer portals and faxes for prior auths and you want one submission and tracking hub across all service lines.
Anterior
Clinician-led AI for health plan clinical reviews
- Founded
- 2023
- HQ
- New York, NY
- Stage
- Series B
- Raised
- $64M
What it does
- AI clinical reasoning against payer medical policies
- Prior authorization review with nurse-in-the-loop workflow
- Auto-approval of clean requests, flagging of edge cases
- Embedded clinicians who tune accuracy in production
- Audit trails for every determination
- Five-day average deployment into plan workflows
Where it's strong
- Clinical accuracy of 99.24% in live production was independently validated by KLAS Research.
- Founded and staffed by clinicians, which helps with medical director buy-in inside plans.
- Deploys into existing UM workflows in days rather than the multi-month integrations typical of payer software.
What buyers should weigh
- Sells only to payers, so provider organizations looking for a submission-side tool are not the buyer.
- Young company with a small number of named reference customers, so diligence on scale is warranted.
- State laws increasingly require licensed clinicians to make denial decisions, so buyers must define where AI output stops and human judgment starts.
Named customers
Geisinger Health Plan
Integrations
Valer (Voluware)
Prior auth submission and tracking automation across payer portals
- Founded
- 2012
- HQ
- Huntington Beach, CA
- Stage
- PE-backed (Hughes & Company)
- Raised
- $7.6M disclosed
What it does
- Automated PA submission to 75+ payer portals
- Auto-completion of 1,000+ payer fax forms
- Automated status checking and verification
- Bi-directional EHR sync using standard 278/275 transactions
- Covers procedures, referrals, and services, not just drugs
- Reporting on turnaround times and staff productivity
Where it's strong
- Covers the messy middle of PA: portal and fax submissions that pure API-based tools cannot reach.
- Bi-directional Epic integration writes auth numbers and statuses back automatically.
- Workflow is configured per client rather than one-size-fits-all, which suits complex health system setups.
What buyers should weigh
- Small company with modest disclosed funding, so evaluate roadmap and support depth against bigger rivals.
- Portal and fax automation depends on payer sites staying stable; expect some maintenance lag when payers change portals.
- Per-client configuration means implementations take real effort compared with plug-and-play point tools.
Named customers
Oregon Health & Science University (OHSU)
Integrations
Compare against the rest of Prior Authorization
Deciding between these two?
First Pass tracks Prior Authorization every week: funding, launches, and what changed since this page was written.